EBIT: Income before interest and taxes.
PDS Biotechnology Corporation (PDSB) had EBIT of $-31.54M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-34.50M |
|
-- |
|
-- |
|
$31.54M |
|
$-31.54M |
|
$-4.12M |
|
$-35.67M |
|
$-35.67M |
|
$-34.50M |
|
$-34.50M |
|
$-34.50M |
|
$-34.50M |
|
|
EBIT |
$-31.54M |
$-29.93M |
|
46.38M |
|
46.38M |
|
$-0.74 |
|
$-0.74 |
|
| Balance Sheet Financials | |
$28.25M |
|
$0.12M |
|
$2.24M |
|
$30.49M |
|
$9.48M |
|
$11.76M |
|
$11.76M |
|
$21.24M |
|
$9.25M |
|
$9.25M |
|
$9.25M |
|
54.88M |
|
| Cash Flow Statement Financials | |
$-27.75M |
|
-- |
|
$12.77M |
|
$41.69M |
|
$26.71M |
|
$-14.98M |
|
$4.11M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.98 |
|
-- |
|
-- |
|
0.56 |
|
1.83 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-27.75M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-372.85% |
|
-372.85% |
|
-113.12% |
|
-164.18% |
|
$0.17 |
|
$-0.60 |
|
$-0.60 |
|